Darunavir inhibits Cryptococcus neoformans/Cryptococcus gattii species complex growth and increases the susceptibility of biofilms to antifungal drugs. Issue 6 (27th June 2020)

• Record Type: Journal Article
• Authors: Brilhante, Raimunda Sâmia Nogueira; Silva, José Alexandre Telmos; Araújo, Géssica dos Santos; Pereira, Vandbergue Santos; Gotay, Wilker Jose Perez; Oliveira, Jonathas Sales de; Guedes, Glaucia Morgana de Melo; Pereira-Neto, Waldemiro Aquino; Castelo-Branco, Débora de Souza Collares Maia; Cordeiro, Rossana de Aguiar; Sidrim, José Júlio Costa; Rocha, Marcos Fábio Gadelha
• Is Part Of: Journal of medical microbiology. Volume 69:Issue 6(2020)
• Page Start: 830
• Page End: 837
• Publication Date: 2020-06-27
• Subjects: antifungal activity -- biofilm -- Cryptococcus species -- darunavir -- synergism; Medical microbiology -- Periodicals; 616.9041
• DOI: 10.1099/jmm.0.001194
• Languages: English
• ISSNs: 0022-2615

Abstract

Abstract : Introduction. Cryptococcus species are pathogens commonly associated with cases of meningoencephalitis in individuals who are immunosuppressed due to AIDS. Aim. The aim was to evaluate the effects of the antiretroviral darunavir alone or associated with fluconazole, 5-flucytosine and amphotericin B against planktonic cells and biofilms of Cryptococcus species. Methodology. Susceptibility testing of darunavir and the common antifungals against 12 members of the Cryptococcus neoformans / Cryptococcus gattii species complex was evaluated by broth microdilution. The interaction between darunavir and antifungals against planktonic cells was tested by a checkerboard assay. The effects of darunavir against biofilm metabolic activity and biomass were evaluated by the XTT reduction assay and crystal violet staining, respectively. Results. Darunavir combined with amphotericin B showed a synergistic interaction against planktonic cells. No antagonistic interaction was observed between darunavir and the antifungals used. All Cryptococcus species strains were strong biofilm producers. Darunavir alone reduced biofilm metabolic activity and biomass when added during and after biofilm formation ( P <0.05). The combination of darunavir with antifungals caused a significant reduction in biofilm metabolic activity and biomass when compared to darunavir alone ( P <0.05). Conclusion. Darunavir presents antifungal activity against planktonic cells of Cryptococcus species and synergism with amphotericin B. In addition, darunavir led to reduced biofilm formation and showed activity against mature biofilms of Cryptococcus species. Activity of the antifungals against mature biofilms was enhanced in the presence of darunavir.